University of California San Francisco
Give to UCSF
A new study provides further proof that regular use of the the HIV antiretroviral drug Truvada can reduce one’s risk for contracting HIV – without increasing sexual risk behavior.
A team led by scientists from UCSF has discovered that recurrent gliomas may have genetic profiles that are markedly different from those of the initial tumors that spawned them.
Children’s risk for developing allergies and asthma is reduced when they are exposed in early infancy to a dog in the household, and now researchers have discovered a reason why.
The nation’s top scientists will gather at UCSF to discuss the latest in research discovery at a special symposium honoring the 2013 and 2014 Breakthrough Prize in Life Sciences Award recipients on Friday, Dec. 13.
The day after the 2014 Breakthrough Prize in Life Sciences winners are announced, the recipients – along with 2013 recipients, UCSF Nobel laureates and other luminaries in the field – will participate in a symposium on the state of research in cancer, genetics, neurobiology and stem cells.
Scientists at the UCSF-affiliated Gladstone Institutes have devised a new molecular sensor that can detect MS at its earliest stages, even before the onset of physical signs.
UC San Francisco’s Health eHeart Study – an ambitious technology-based cardiovascular research study – has garnered the support from the American Heart Association, the largest U.S. non-profit organization dedicated to reducing disability and deaths caused by cardiovascular disease and stroke.
UCSF has been awarded a major federal grant to “transform and revolutionize” the treatment of prostate cancer, the second most common form of cancer among American men.
Technology and health care often go hand in hand, and UC San Francisco highlighted this budding alliance at the 11th annual Dreamforce conference, hosted by cloud computing giant Salesforce.com.
Over more than two decades in Africa, UCSF researchers have approached their scientific work with a dual aim: treat disease while helping to sustainably build up the local health care system.
Top thinkers gather at UCSF to help make the new field a reality.
Pamela Munster, MD, is program leader of Developmental Therapeutics at UCSF’s Helen Diller Family Comprehensive Cancer Center. She shares a breast cancer story here – her own.
UCSF is one of the first pharmacy schools in the nation to offer its students genetic testing for drug response. It’s just one way they're learning about the potential of precision medicine.
UCSF’s Yuet Wai Kan, an internationally recognized leader in the field of human genetics, will be honored at the Personalized Medicine World Conference, PMWC 2014, to be held in January 2014 in Silicon Valley.
A team led by UCSF scientists has identified the disruption of a single type of cell – in a particular brain region and at a particular time in brain development – as a significant factor in the emergence of autism.
The protein in cells that most often drives the development of cancers has eluded scientists’ efforts to block it for three decades — until now.
The fall 2013 UCSF Magazine, which features the promise of precision medicine, is now available online.
Precision Medicine Pillar No. 5: Omics Medicine. Molecular biologist Nevan Krogan's work is not only illuminating how genes and proteins function, it's also shedding light on the underlying biology of disease for each person.
Precision Medicine Pillar No. 6: Digital Health. The Center for Digital Health Innovation shepherds the development of digital health innovations created at UCSF and validates the effectiveness of devices from both inside and outside the institution.
Precision Medicine Pillar No. 4: Computational Health Sciences. Computationally intensive approaches are used to analyze and cross-analyze large but discrete collections of data, such as patient health histories and genetic makeup.
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
Precision Medicine Pillar No. 2: Basic Discovery. The long path to developing potent new treatments often starts with an observation in the lab that then leads to a question about a fundamental life process.
Precision Medicine Pillar No. 1: Knowledge Network. With an increased ability to harvest information automatically and more powerfully, scientists can find the connections among discoveries that would otherwise go unrecognized.
Today, with a host of tools garnered from precision medicine, patients can benefit from precise and effective therapies for some of the world's most daunting illnesses. <em>UCSF Magazine</em> explores the promise of precision medicine.
With inexpensive genetics kits flooding the market, both consumers — and their doctors — still lack basic information about what to do, if anything, with what they learn about their own genomes.
UCSF faculty members will discuss their cutting-edge approaches to researching and delivering health care on at Dreamforce 2013’s “Unusual Thinkers” track.
Researchers at the UCSF-affiliated Gladstone Institutes have discovered how the activation of specific stretches of DNA control the development of uniquely human characteristics.
UCSF scientists were able to arrest, and even reverse, tissue scarring of the liver, kidneys and lungs in mice. The scarring, also known as fibrosis, is a major factor in nearly half of all deaths in developed countries.
David Baltimore, PhD, will present the 2013 Gladstone Distinguished Lecture on Wednesday, Nov. 20. The lecture, titled, “The Role of MicroRNAs in Immune Functions,” will begin at 4 p.m. in Gladstone’s Robert Mahley Auditorium.
UCSF's Pierre Theodore is the first surgeon to use the tech device, Google Glass, as a surgical tool to make a patient's CT and X-ray images available to him for quick reference while in the operating room.
